Oncolytic murine autonomous parvovirus, a candidate vector for glioma gene therapy, is innocuous to normal and immunocompetent mouse glial cells

Cell and Tissue Research

Volumn 325, Issue 3, 2006, Pages 423-436

  Abschuetz, Anette ^a   Kehl, Timo ^a   Geibig, Renate ^a   Leuchs, Barbara ^a   Rommelaere, Jean ^a   Régnier Vigouroux, Anne ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Astrocytoma; Glial cells; Interferon; Lipopolysaccharide; Mouse; Parvovirus

Indexed keywords

CYTOTOXIC FACTOR; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; ONCOLYTIC VIRUS; PARVOVIRUS VECTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRAL NON STRUCTURAL NS1 PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; AUTONOMIC NERVOUS SYSTEM; CELL FRACTIONATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; GLIA CELL; GLIOMA; HOST; IMMUNOCOMPETENT CELL; MICROGLIA; MOUSE; MOUSE STRAIN; NONHUMAN; PARVOVIRUS INFECTION; PRIORITY JOURNAL; PROGENY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TUMOR CELL CULTURE; VIRAL GENE THERAPY; VIRION; VIRUS REPLICATION;

ANIMALS; CELL LINE; CELL LINE, TUMOR; GENE THERAPY; GENETIC VECTORS; GLIOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MINUTE VIRUS OF MICE; PARVOVIRUS;

MURINAE; PARVOVIRUS;

EID: 33746396481     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-006-0199-z     Document Type: Article

References (46)

1. Aloisi F (2001) Immune function of microglia. Glia 36:165-179
2. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW (1993) Cytotoxicity of microglia. Glia 7:111-118
3. Bashir T, Horlein R, Rommelaere J, Willwand K (2000) Cyclin A activates the DNA polymerase delta-dependent elongation machinery in vitro: a parvovirus DNA replication model. Proc Natl Acad Sci USA 97:5522-5527
4. Benveniste EN (1992) Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 263:C1-C16
5. Bretz F, Genz A, Hothorn LA (2001) On the numerical availability of multiple comparison procedures. Biomed J 43:64-66
6. Brownstein DG, Smith AL, Jacoby RO, Johnson EA, Hansen G, Tattersall P (1991) Pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype. Lab Invest 65:357-364
7. Burudi EM, Riese S, Stahl PD, Regnier-Vigouroux A (1999) Identification and functional characterization of the mannose receptor in astrocytes. Glia 25:44-55
8. Christensen J, Cotmore SF, Tattersall P (1995) Minute virus of mice transcriptional activator protein NS1 binds directly to the transactivation region of the viral P38 promoter in a strictly ATP-dependent manner. J Virol 69:5422-5430
9. Chung IY, Benveniste EN (1990) Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol 144:2999-3007
10. Cornelis JJ, Salome N, Dinsart C, Rommelaere J (2004) Vectors based on autonomous parvoviruses: novel tools to treat cancer? J Gene Med 6 (Suppl 1):S193-S202
11. Cotmore SF, Tattersall P (1986) The NS-1 polypeptide of the autonomous parvovirus MVM is a nuclear phosphoprotein. Virus Res 4:243-250
12. Cotmore SF, Tattersall P (1987) The autonomously replicating parvoviruses of vertebrates. Adv Virus Res 33:91-174
13. Dong Y, Benveniste EN (2001) Immune function of astrocytes. Glia 36:180-190
14. Dupont F, Avalosse B, Karim A, Mine N, Bosseler M, Maron A, Van den Broeke AV, Ghanem GE, Burny A, Zeicher M (2000) Tumor-selective gene transduction and cell killing with an oncotropic autonomous parvovirus-based vector. Gene Ther 7:790-796
15. Eichwald V, Daeffler L, Klein M, Rommelaere J, Salome N (2002) The NS2 proteins of parvovirus minute virus of mice are required for efficient nuclear egress of progeny virions in mouse cells. J Virol 76:10307-10319
16. Fraser H (1971) Astrocytomas in an inbred mouse strain. J Pathol 103:266-270
17. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A (1987) Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol 17:1271-1278
18. Fu Y, Ishii KK, Munakata Y, Saitoh T, Kaku M, Sasaki T (2002) Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2. J Virol 76:5395-5403
19. Fulci G, Chiocca EA (2003) Oncolytic viruses for the therapy of brain tumors and other solid malignancies: a review. Front Biosci 8:e346-e360
20. Gresser O, Weber E, Hellwig A, Riese S, Regnier-Vigoureux A (2001) Immunocompetent astrocytes and microglia display major differences in the processing of the invariant chain and in the expression of active cathepsin L and cathepsin S. Eur J Immunol 31:1813-1824
21. Harell FE (2001) Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. Springer, Berlin Heidelberg New York
22. Herrero YCM, Cornelis JJ, Herold-Mende C, Rommelaere J, Schlehofer JR, Geletneky K (2004) Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing. Int J Cancer 109:76-84
23. Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Statist 6:65-70
24. Linser P, Bruning H, Armentrout RW (1979) Uptake of minute virus of mice into cultured rodent cells. J Virol 31:537-545
25. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15:1311-1333
26. Margolis G, Kilham L (1975) Problems of human concern arising from animal models of intrauterine and neonatal infections due to viruses: a review. II. Pathologic studies. Prog Med Virol 20:144-179
27. Mucke L, Eddleston M (1993) Astrocytes in infectious and immune-mediated diseases of the central nervous system. FASEB J 7:1226-1232
28. Murata J, Ricciardi-Castagnoli P, Dessous L'Eglise Mange P, Martin F, Juillerat-Jeanneret L (1997) Microglial cells induce cytotoxic effects toward colon carcinoma cells: measurement of tumor cytotoxicity with a gamma-glutamyl transpeptidase assay. Int J Cancer 70:169-174
29. Nagano N, Sasaki H, Aoyagi M, Hirakawa K (1993) Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol (Berl) 86:117-125
30. Ohshima T, Iwama M, Ueno Y, Sugiyama F, Nakajima T, Fukamizu A, Yagami K (1998) Induction of apoptosis in vitro and in vivo by H-1 parvovirus infection. J Gen Virol 79:3067-3071
31. Previsani N, Fontana S, Hirt B, Beard P (1997) Growth of the parvovirus minute virus of mice MVMp3 in EL4 lymphocytes is restricted after cell entry and before viral DNA amplification: cell-specific differences in virus uncoating in vitro. J Virol 71:7769-7780
32. Ramirez JC, Fairen A, Almendral JM (1996) Parvovirus minute virus of mice strain in multiplication and pathogenesis in the newborn mouse brain are restricted to proliferative areas and to migratory cerebellar young neurons. J Virol 70:8109-8116
33. Roggendorf W, Strupp S, Paulus W (1996) Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol (Berl) 92:288-293
34. Rommelaere J, Cornelis JJ (1991) Antineoplastic activity of parvoviruses. J Virol Methods 33:233-251
35. Ros C, Burckhardt CJ, Kempf C (2002) Cytoplasmic trafficking of minute virus of mice: low-pH requirement, routing to late endosomes, and proteasome interaction. J Virol 76:12634-12645
36. Rosales AA, Roque RS (1997) Microglia-derived cytotoxic factors. Part I: Inhibition of tumor cell growth in vitro. Brain Res 748:195-204
37. Rubio MP, Guerra S, Almendral JM (2001) Genome replication and postencapsidation functions mapping to the nonstructural gene restrict the host range of a murine parvovirus in human cells. J Virol 75:11573-11582
38. Sawada M, Kondo N, Suzumura A, Marunouchi T (1989) Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 491:394-397
39. Serano RD, Pegram CN, Bigner DD (1980) Tumorigenic cell culture lines from a spontaneous VM/Dk murine astrocytoma (SMA). Acta Neuropathol (Berl) 51:53-64
40. Shaughnessy E, Lu D, Chatterjee S, Wong KK (1996) Parvoviral vectors for the gene therapy of cancer. Semin Oncol 23: 159-171
41. Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503-517
42. Tracey KJ, Cerami A (1993) Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 9:317-343
43. Watters JJ, Schartner JM, Badie B (2005) Microglia function in brain tumors. J Neurosci Res 81:447-455
44. Wiedbrauk DL, Bloom ME, Lodmell DL (1986) Mink parvoviruses and interferons: in vitro studies. J Virol 60:1179-1182
45. Zimmer H, Riese S, Regnier-Vigouroux A (2003) Functional characterization of mannose receptor expressed by immunocompetent mouse microglia. Glia 42:89-100
46. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ, Muzyczka N (1999) Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 6:973-985